Table of Contents 1 Crude Heparin Market Overview 1.1 Product Overview and Scope of Crude Heparin 1.2 Crude Heparin Segment by Type 1.2.1 Global Crude Heparin Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Pig Intestine Mucosa Heparin 1.2.3 Bovine Heparin and Others 1.3 Crude Heparin Segment by Application 1.3.1 Crude Heparin Sales Comparison by Application: 2020 VS 2026 1.3.2 UFH 1.3.3 LMWH 1.4 Global Crude Heparin Market Size Estimates and Forecasts 1.4.1 Global Crude Heparin Revenue 2015-2026 1.4.2 Global Crude Heparin Sales 2015-2026 1.4.3 Crude Heparin Market Size by Region: 2020 Versus 2026 2 Global Crude Heparin Market Competition by Manufacturers 2.1 Global Crude Heparin Sales Market Share by Manufacturers (2015-2020) 2.2 Global Crude Heparin Revenue Share by Manufacturers (2015-2020) 2.3 Global Crude Heparin Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Crude Heparin Manufacturing Sites, Area Served, Product Type 2.5 Crude Heparin Market Competitive Situation and Trends 2.5.1 Crude Heparin Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Crude Heparin Players (Opinion Leaders) 3 Crude Heparin Retrospective Market Scenario by Region 3.1 Global Crude Heparin Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Crude Heparin Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Crude Heparin Market Facts & Figures by Country 3.3.1 North America Crude Heparin Sales by Country 3.3.2 North America Crude Heparin Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Crude Heparin Market Facts & Figures by Country 3.4.1 Europe Crude Heparin Sales by Country 3.4.2 Europe Crude Heparin Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Crude Heparin Market Facts & Figures by Region 3.5.1 Asia Pacific Crude Heparin Sales by Region 3.5.2 Asia Pacific Crude Heparin Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Crude Heparin Market Facts & Figures by Country 3.6.1 Latin America Crude Heparin Sales by Country 3.6.2 Latin America Crude Heparin Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Crude Heparin Market Facts & Figures by Country 3.7.1 Middle East and Africa Crude Heparin Sales by Country 3.7.2 Middle East and Africa Crude Heparin Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Crude Heparin Historic Market Analysis by Type 4.1 Global Crude Heparin Sales Market Share by Type (2015-2020) 4.2 Global Crude Heparin Revenue Market Share by Type (2015-2020) 4.3 Global Crude Heparin Price Market Share by Type (2015-2020) 4.4 Global Crude Heparin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Crude Heparin Historic Market Analysis by Application 5.1 Global Crude Heparin Sales Market Share by Application (2015-2020) 5.2 Global Crude Heparin Revenue Market Share by Application (2015-2020) 5.3 Global Crude Heparin Price by Application (2015-2020) 6 Company Profiles and Key Figures in Crude Heparin Business 6.1 Shenzhen Hepalink Pharmaceutical Group Co., Ltd 6.1.1 Corporation Information 6.1.2 Shenzhen Hepalink Pharmaceutical Group Co., Ltd Description, Business Overview and Total Revenue 6.1.3 Shenzhen Hepalink Pharmaceutical Group Co., Ltd Crude Heparin Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Shenzhen Hepalink Pharmaceutical Group Co., Ltd Products Offered 6.1.5 Shenzhen Hepalink Pharmaceutical Group Co., Ltd Recent Development 6.2 Bioiberica 6.2.1 Bioiberica Crude Heparin Production Sites and Area Served 6.2.2 Bioiberica Description, Business Overview and Total Revenue 6.2.3 Bioiberica Crude Heparin Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Bioiberica Products Offered 6.2.5 Bioiberica Recent Development 6.3 Sanofi 6.3.1 Sanofi Crude Heparin Production Sites and Area Served 6.3.2 Sanofi Description, Business Overview and Total Revenue 6.3.3 Sanofi Crude Heparin Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Sanofi Products Offered 6.3.5 Sanofi Recent Development 6.4 Fengrun Biological Technology Co., Ltd. 6.4.1 Fengrun Biological Technology Co., Ltd. Crude Heparin Production Sites and Area Served 6.4.2 Fengrun Biological Technology Co., Ltd. Description, Business Overview and Total Revenue 6.4.3 Fengrun Biological Technology Co., Ltd. Crude Heparin Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Fengrun Biological Technology Co., Ltd. Products Offered 6.4.5 Fengrun Biological Technology Co., Ltd. Recent Development 6.5 Nanjing King-friend Biochemical Pharmaceutical 6.5.1 Nanjing King-friend Biochemical Pharmaceutical Crude Heparin Production Sites and Area Served 6.5.2 Nanjing King-friend Biochemical Pharmaceutical Description, Business Overview and Total Revenue 6.5.3 Nanjing King-friend Biochemical Pharmaceutical Crude Heparin Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Nanjing King-friend Biochemical Pharmaceutical Products Offered 6.5.5 Nanjing King-friend Biochemical Pharmaceutical Recent Development 6.6 Hebei Changshan Biochemical Pharmaceutical 6.6.1 Hebei Changshan Biochemical Pharmaceutical Crude Heparin Production Sites and Area Served 6.6.2 Hebei Changshan Biochemical Pharmaceutical Description, Business Overview and Total Revenue 6.6.3 Hebei Changshan Biochemical Pharmaceutical Crude Heparin Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Hebei Changshan Biochemical Pharmaceutical Products Offered 6.6.5 Hebei Changshan Biochemical Pharmaceutical Recent Development 6.7 Changzhou Qianhong Biopharma Co.,Ltd 6.6.1 Changzhou Qianhong Biopharma Co.,Ltd Crude Heparin Production Sites and Area Served 6.6.2 Changzhou Qianhong Biopharma Co.,Ltd Description, Business Overview and Total Revenue 6.6.3 Changzhou Qianhong Biopharma Co.,Ltd Crude Heparin Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Changzhou Qianhong Biopharma Co.,Ltd Products Offered 6.7.5 Changzhou Qianhong Biopharma Co.,Ltd Recent Development 6.8 Aspen Oss 6.8.1 Aspen Oss Crude Heparin Production Sites and Area Served 6.8.2 Aspen Oss Description, Business Overview and Total Revenue 6.8.3 Aspen Oss Crude Heparin Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Aspen Oss Products Offered 6.8.5 Aspen Oss Recent Development 6.9 Hepac (Darling Ingredients) 6.9.1 Hepac (Darling Ingredients) Crude Heparin Production Sites and Area Served 6.9.2 Hepac (Darling Ingredients) Description, Business Overview and Total Revenue 6.9.3 Hepac (Darling Ingredients) Crude Heparin Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Hepac (Darling Ingredients) Products Offered 6.9.5 Hepac (Darling Ingredients) Recent Development 6.10 Yantai Dongcheng Biochemicals Co., Ltd 6.10.1 Yantai Dongcheng Biochemicals Co., Ltd Crude Heparin Production Sites and Area Served 6.10.2 Yantai Dongcheng Biochemicals Co., Ltd Description, Business Overview and Total Revenue 6.10.3 Yantai Dongcheng Biochemicals Co., Ltd Crude Heparin Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Yantai Dongcheng Biochemicals Co., Ltd Products Offered 6.10.5 Yantai Dongcheng Biochemicals Co., Ltd Recent Development 6.11 Huaian MDC Pharmaceutical Co., Ltd 6.11.1 Huaian MDC Pharmaceutical Co., Ltd Crude Heparin Production Sites and Area Served 6.11.2 Huaian MDC Pharmaceutical Co., Ltd Crude Heparin Description, Business Overview and Total Revenue 6.11.3 Huaian MDC Pharmaceutical Co., Ltd Crude Heparin Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Huaian MDC Pharmaceutical Co., Ltd Products Offered 6.11.5 Huaian MDC Pharmaceutical Co., Ltd Recent Development 7 Crude Heparin Manufacturing Cost Analysis 7.1 Crude Heparin Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Crude Heparin 7.4 Crude Heparin Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Crude Heparin Distributors List 8.3 Crude Heparin Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Crude Heparin Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Crude Heparin by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Crude Heparin by Type (2021-2026) 10.2 Crude Heparin Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Crude Heparin by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Crude Heparin by Application (2021-2026) 10.3 Crude Heparin Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Crude Heparin by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Crude Heparin by Region (2021-2026) 10.4 North America Crude Heparin Estimates and Projections (2021-2026) 10.5 Europe Crude Heparin Estimates and Projections (2021-2026) 10.6 Asia Pacific Crude Heparin Estimates and Projections (2021-2026) 10.7 Latin America Crude Heparin Estimates and Projections (2021-2026) 10.8 Middle East and Africa Crude Heparin Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Crude Heparin Sales (MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Crude Heparin Sales (MT) Comparison by Application: 2020 VS 2026 Table 3. Global Crude Heparin Market Size by Type (MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Crude Heparin Manufacturers Covered in This Study Table 5. Global Crude Heparin Sales (MT) by Manufacturers (2015-2020) Table 6. Global Crude Heparin Sales Share by Manufacturers (2015-2020) Table 7. Global Crude Heparin Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Crude Heparin Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Crude Heparin Average Price (K USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Crude Heparin Sales Sites and Area Served Table 11. Manufacturers Crude Heparin Product Types Table 12. Global Crude Heparin Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Crude Heparin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Crude Heparin as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Crude Heparin Players Table 16. Global Crude Heparin Sales (MT) by Region (2015-2020) Table 17. Global Crude Heparin Sales Market Share by Region (2015-2020) Table 18. Global Crude Heparin Revenue (Million US$) by Region (2015-2020) Table 19. Global Crude Heparin Revenue Market Share by Region (2015-2020) Table 20. North America Crude Heparin Sales by Country (2015-2020) (MT) Table 21. North America Crude Heparin Sales Market Share by Country (2015-2020) Table 22. North America Crude Heparin Revenue by Country (2015-2020) (US$ Million) Table 23. North America Crude Heparin Revenue Market Share by Country (2015-2020) Table 24. Europe Crude Heparin Sales by Country (2015-2020) (MT) Table 25. Europe Crude Heparin Sales Market Share by Country (2015-2020) Table 26. Europe Crude Heparin Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Crude Heparin Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Crude Heparin Sales by Region (2015-2020) (MT) Table 29. Asia Pacific Crude Heparin Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Crude Heparin Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Crude Heparin Revenue Market Share by Region (2015-2020) Table 32. Latin America Crude Heparin Sales by Country (2015-2020) (MT) Table 33. Latin America Crude Heparin Sales Market Share by Country (2015-2020) Table 34. Latin America Crude Heparin Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Crude Heparin Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Crude Heparin Sales by Country (2015-2020) (MT) Table 37. Middle East and Africa Crude Heparin Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Crude Heparin Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Crude Heparin Revenue Market Share by Country (2015-2020) Table 40. Global Crude Heparin Sales (MT) by Type (2015-2020) Table 41. Global Crude Heparin Sales Share by Type (2015-2020) Table 42. Global Crude Heparin Revenue (Million US$) by Type (2015-2020) Table 43. Global Crude Heparin Revenue Share by Type (2015-2020) Table 44. Global Crude Heparin Price (K USD/MT) by Type (2015-2020) Table 45. Global Crude Heparin Sales (MT) by Application (2015-2020) Table 46. Global Crude Heparin Sales Market Share by Application (2015-2020) Table 47. Global Crude Heparin Sales Growth Rate by Application (2015-2020) Table 48. Shenzhen Hepalink Pharmaceutical Group Co., Ltd Crude Heparin Corporation Information Table 49. Shenzhen Hepalink Pharmaceutical Group Co., Ltd Description and Business Overview Table 50. Shenzhen Hepalink Pharmaceutical Group Co., Ltd Crude Heparin Sales (MT), Revenue (Million US$), Price (K USD/MT) and Gross Margin (2015-2020) Table 51. Shenzhen Hepalink Pharmaceutical Group Co., Ltd Main Product Table 52. Shenzhen Hepalink Pharmaceutical Group Co., Ltd Recent Development Table 53. Bioiberica Crude Heparin Corporation Information Table 54. Bioiberica Corporation Information Table 55. Bioiberica Crude Heparin Sales (MT), Revenue (Million US$), Price (K USD/MT) and Gross Margin (2015-2020) Table 56. Bioiberica Main Product Table 57. Bioiberica Recent Development Table 58. Sanofi Crude Heparin Corporation Information Table 59. Sanofi Corporation Information Table 60. Sanofi Crude Heparin Sales (MT), Revenue (Million US$), Price (K USD/MT) and Gross Margin (2015-2020) Table 61. Sanofi Main Product Table 62. Sanofi Recent Development Table 63. Fengrun Biological Technology Co., Ltd. Crude Heparin Corporation Information Table 64. Fengrun Biological Technology Co., Ltd. Corporation Information Table 65. Fengrun Biological Technology Co., Ltd. Crude Heparin Sales (MT), Revenue (Million US$), Price (K USD/MT) and Gross Margin (2015-2020) Table 66. Fengrun Biological Technology Co., Ltd. Main Product Table 67. Fengrun Biological Technology Co., Ltd. Recent Development Table 68. Nanjing King-friend Biochemical Pharmaceutical Crude Heparin Corporation Information Table 69. Nanjing King-friend Biochemical Pharmaceutical Corporation Information Table 70. Nanjing King-friend Biochemical Pharmaceutical Crude Heparin Sales (MT), Revenue (Million US$), Price (K USD/MT) and Gross Margin (2015-2020) Table 71. Nanjing King-friend Biochemical Pharmaceutical Main Product Table 72. Nanjing King-friend Biochemical Pharmaceutical Recent Development Table 73. Hebei Changshan Biochemical Pharmaceutical Crude Heparin Corporation Information Table 74. Hebei Changshan Biochemical Pharmaceutical Corporation Information Table 75. Hebei Changshan Biochemical Pharmaceutical Crude Heparin Sales (MT), Revenue (Million US$), Price (K USD/MT) and Gross Margin (2015-2020) Table 76. Hebei Changshan Biochemical Pharmaceutical Main Product Table 77. Hebei Changshan Biochemical Pharmaceutical Recent Development Table 78. Changzhou Qianhong Biopharma Co.,Ltd Crude Heparin Corporation Information Table 79. Changzhou Qianhong Biopharma Co.,Ltd Corporation Information Table 80. Changzhou Qianhong Biopharma Co.,Ltd Crude Heparin Sales (MT), Revenue (Million US$), Price (K USD/MT) and Gross Margin (2015-2020) Table 81. Changzhou Qianhong Biopharma Co.,Ltd Main Product Table 82. Changzhou Qianhong Biopharma Co.,Ltd Recent Development Table 83. Aspen Oss Crude Heparin Corporation Information Table 84. Aspen Oss Corporation Information Table 85. Aspen Oss Crude Heparin Sales (MT), Revenue (Million US$), Price (K USD/MT) and Gross Margin (2015-2020) Table 86. Aspen Oss Main Product Table 87. Aspen Oss Recent Development Table 88. Hepac (Darling Ingredients) Crude Heparin Corporation Information Table 89. Hepac (Darling Ingredients) Corporation Information Table 90. Hepac (Darling Ingredients) Crude Heparin Sales (MT), Revenue (Million US$), Price (K USD/MT) and Gross Margin (2015-2020) Table 91. Hepac (Darling Ingredients) Main Product Table 92. Hepac (Darling Ingredients) Recent Development Table 93. Yantai Dongcheng Biochemicals Co., Ltd Crude Heparin Corporation Information Table 94. Yantai Dongcheng Biochemicals Co., Ltd Corporation Information Table 95. Yantai Dongcheng Biochemicals Co., Ltd Crude Heparin Sales (MT), Revenue (Million US$), Price (K USD/MT) and Gross Margin (2015-2020) Table 96. Yantai Dongcheng Biochemicals Co., Ltd Main Product Table 97. Yantai Dongcheng Biochemicals Co., Ltd Recent Development Table 98. Huaian MDC Pharmaceutical Co., Ltd Crude Heparin Corporation Information Table 99. Huaian MDC Pharmaceutical Co., Ltd Corporation Information Table 100. Huaian MDC Pharmaceutical Co., Ltd Crude Heparin Sales (MT), Revenue (Million US$), Price (K USD/MT) and Gross Margin (2015-2020) Table 101. Huaian MDC Pharmaceutical Co., Ltd Main Product Table 102. Huaian MDC Pharmaceutical Co., Ltd Recent Development Table 103. Sales Base and Market Concentration Rate of Raw Material Table 104. Key Suppliers of Raw Materials Table 105. Crude Heparin Distributors List Table 106. Crude Heparin Customers List Table 107. Market Key Trends Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 109. Key Challenges Table 110. Global Crude Heparin Sales (MT) Forecast by Type (2021-2026) Table 111. Global Crude Heparin Sales Market Share Forecast by Type (2021-2026) Table 112. Global Crude Heparin Revenue (Million US$) Forecast by Type (2021-2026) Table 113. Global Crude Heparin Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 114. Global Crude Heparin Sales (MT) Forecast by Application (2021-2026) Table 115. Global Crude Heparin Revenue (Million US$) Forecast by Application (2021-2026) Table 116. Global Crude Heparin Sales (MT) Forecast by Region (2021-2026) Table 117. Global Crude Heparin Sales Market Share Forecast by Region (2021-2026) Table 118. Global Crude Heparin Revenue Forecast by Region (2021-2026) (US$ Million) Table 119. Global Crude Heparin Revenue Market Share Forecast by Region (2021-2026) Table 120. Research Programs/Design for This Report Table 121. Key Data Information from Secondary Sources Table 122. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Crude Heparin Figure 2. Global Crude Heparin Sales Market Share by Type: 2020 VS 2026 Figure 3. Pig Intestine Mucosa Heparin Product Picture Figure 4. Bovine Heparin and Others Product Picture Figure 5. Global Crude Heparin Consumption Market Share by Application: 2020 VS 2026 Figure 6. UFH Figure 7. LMWH Figure 8. Global Crude Heparin Market Size 2015-2026 (US$ Million) Figure 9. Global Crude Heparin Sales Capacity (MT) (2015-2026) Figure 10. Global Crude Heparin Market Size Market Share by Region: 2020 Versus 2026 Figure 11. Crude Heparin Sales Share by Manufacturers in 2020 Figure 12. Global Crude Heparin Revenue Share by Manufacturers in 2019 Figure 13. The Global 5 and 10 Largest Players: Market Share by Crude Heparin Revenue in 2019 Figure 14. Crude Heparin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 15. Global Crude Heparin Sales Market Share by Region (2015-2020) Figure 16. Global Crude Heparin Sales Market Share by Region in 2019 Figure 17. Global Crude Heparin Revenue Market Share by Region (2015-2020) Figure 18. Global Crude Heparin Revenue Market Share by Region in 2019 Figure 19. North America Crude Heparin Sales Market Share by Country in 2019 Figure 20. North America Crude Heparin Revenue Market Share by Country in 2019 Figure 21. U.S. Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 22. U.S. Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 23. Canada Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 24. Canada Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 25. Europe Crude Heparin Sales Market Share by Country in 2019 Figure 26. Europe Crude Heparin Revenue Market Share by Country in 2019 Figure 27. Germany Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 28. Germany Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. France Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 30. France Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 31. U.K. Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 32. U.K. Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. Italy Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 34. Italy Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. Russia Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 36. Russia Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Asia Pacific Crude Heparin Sales Market Share by Region in 2019 Figure 38. Asia Pacific Crude Heparin Revenue Market Share by Region in 2019 Figure 39. China Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 40. China Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Japan Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 42. Japan Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. South Korea Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 44. South Korea Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. India Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 46. India Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. Australia Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 48. Australia Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. Taiwan Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 50. Taiwan Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Indonesia Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 52. Indonesia Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Thailand Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 54. Thailand Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Malaysia Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 56. Malaysia Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Philippines Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 58. Philippines Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Vietnam Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 60. Vietnam Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Latin America Crude Heparin Sales Market Share by Country in 2019 Figure 62. Latin America Crude Heparin Revenue Market Share by Country in 2019 Figure 63. Mexico Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 64. Mexico Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Brazil Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 66. Brazil Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. Argentina Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 68. Argentina Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Middle East and Africa Crude Heparin Sales Market Share by Country in 2019 Figure 70. Middle East and Africa Crude Heparin Revenue Market Share by Country in 2019 Figure 71. Turkey Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 72. Turkey Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Saudi Arabia Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 74. Saudi Arabia Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. U.A.E Crude Heparin Sales Growth Rate (2015-2020) (MT) Figure 76. U.A.E Crude Heparin Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Sales Market Share of Crude Heparin by Type (2015-2020) Figure 78. Sales Market Share of Crude Heparin by Type in 2019 Figure 79. Revenue Share of Crude Heparin by Type (2015-2020) Figure 80. Revenue Market Share of Crude Heparin by Type in 2019 Figure 81. Global Crude Heparin Sales Growth by Type (2015-2020) (MT) Figure 82. Global Crude Heparin Sales Market Share by Application (2015-2020) Figure 83. Global Crude Heparin Sales Market Share by Application in 2019 Figure 84. Global Revenue Share of Crude Heparin by Application (2015-2020) Figure 85. Global Revenue Share of Crude Heparin by Application in 2020 Figure 86. Shenzhen Hepalink Pharmaceutical Group Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 87. Bioiberica Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Fengrun Biological Technology Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Nanjing King-friend Biochemical Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Hebei Changshan Biochemical Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Changzhou Qianhong Biopharma Co.,Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Aspen Oss Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Hepac (Darling Ingredients) Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Yantai Dongcheng Biochemicals Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Huaian MDC Pharmaceutical Co., Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Price Trend of Key Raw Materials Figure 98. Manufacturing Cost Structure of Crude Heparin Figure 99. Manufacturing Process Analysis of Crude Heparin Figure 100. Crude Heparin Industrial Chain Analysis Figure 101. Channels of Distribution Figure 102. Distributors Profiles Figure 103. Porter's Five Forces Analysis Figure 104. North America Crude Heparin Sales (MT) and Growth Rate Forecast (2021-2026) Figure 105. North America Crude Heparin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 106. Europe Crude Heparin Sales (MT) and Growth Rate Forecast (2021-2026) Figure 107. Europe Crude Heparin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 108. Latin America Crude Heparin Sales (MT) and Growth Rate Forecast (2021-2026) Figure 109. Latin America Crude Heparin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Middle East and Africa Crude Heparin Sales (MT) and Growth Rate Forecast (2021-2026) Figure 111. Middle East and Africa Crude Heparin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Asia Pacific Crude Heparin Sales (MT) and Growth Rate Forecast (2021-2026) Figure 113. Asia Pacific Crude Heparin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 114. Bottom-up and Top-down Approaches for This Report Figure 115. Data Triangulation Figure 116. Key Executives Interviewed

Shenzhen Hepalink Pharmaceutical Group Co., Ltd Bioiberica Sanofi Fengrun Biological Technology Co., Ltd. Nanjing King-friend Biochemical Pharmaceutical Hebei Changshan Biochemical Pharmaceutical Changzhou Qianhong Biopharma Co.,Ltd Aspen Oss Hepac (Darling Ingredients) Yantai Dongcheng Biochemicals Co., Ltd Huaian MDC Pharmaceutical Co., Ltd